Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Huntington's disease | R-HSA-1643685 | 0 | oxybutynin | 4634 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | oxybutynin | 4634 | drug-path |
Pancreatic cancer | R-HSA-9700206 | map05212 | oxybutynin | 4634 | drug-path |
Prostate cancer | R-HSA-2990872 | map05215 | oxybutynin | 4634 | drug-path |
ECM-receptor interaction | R-HSA-373711 | map04512 | oxybutynin | 4634 | drug-path |
Parkinson's disease | R-HSA-1643685 | 0 | oxybutynin | 4634 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | oxybutynin | 4634 | drug-path |
Tight junction | R-HSA-2134514 | map04530 | oxybutynin | 4634 | drug-path |
Calcium signaling pathway | R-HSA-381753 | map04020 | oxybutynin | 4634 | drug-path |
Renal cell carcinoma | R-HSA-9794523 | map05211 | benzydamine | 12555 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | benzydamine | 12555 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | benzydamine | 12555 | drug-path |
Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | benzydamine | 12555 | drug-path |
Focal adhesion | R-HSA-354113 | map04510 | benzydamine | 12555 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | benzydamine | 12555 | drug-path |
Asthma | R-HSA-444620 | map05310 | benzydamine | 12555 | drug-path |
Toll-like receptor signaling pathway | R-HSA-168898 | map04620 | benzydamine | 12555 | drug-path |
Colorectal cancer | R-HSA-4791275 | map05210 | benzydamine | 12555 | drug-path |
Graft-versus-host disease | R-HSA-1643685 | map05332 | benzydamine | 12555 | drug-path |
Tight junction | R-HSA-2134514 | map04530 | benzydamine | 12555 | drug-path |